If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com).  The website is updated approximately twice a month.

PDP Press Releases/ statements

IAVI 

• 5 Aug: ENABLE project launches to evaluate the enhancement of treatment of HIV in infants by adding monoclonal antibodies

IVCC

 • 20 Aug: World Mosquito Day: Developing the next generation of tools to stay ahead of insecticide resistance 

TB Alliance

• 14 Jul: TB Alliance case study on expanding access to lifesaving tuberculosis treatments published by INSEAD

GARDP 

• 22 Jul: Last-resort antibiotics remain out of reach in Latin America and the Caribbean, review warns

• 27 Jul: Thai FDA approves NUZOLVENCE® (zoliflodacin) just six months after US authorization

Population Council

 • 4 Feb: Contraline and Population Council Execute Global Exclusive License Agreement for NES/T Male Contraception Gel

PATH

• 2 Jul: From innovation to access: ensuring lifesaving solutions reach those who need them

• 14 Jul: PATH and Unitaid partner with GiveWell to strengthen integrated HIV and syphilis testing for mothers, newborns, and their families

• 27 Jul: The diagnostics deficit: Funding, access, and preparedness gaps in African health systems

MMV

• 9 Jul: MMV and deepmirror continue partnership to advance AI tool for global health drug discovery

• 15 Jul: New malaria drug candidate shows early promise in human study

• 21 Jul: Japan convenes global leaders in malaria research and development to strengthen partnerships for innovative prevention and treatment tools

DNDi

• 20 Aug: Mycetoma at 10: What recognition made possible

FIND

•  10 Jul: FIND Board Announces Board Chair Transition

IVI

• 8 Jun: IVI partners in ACT-CHIK consortium to advance chikungunya vaccine development and manufacturing in Africa

• 26 Jun: IVI, KDCA, and RIGHT Foundation host 2026 Global Vaccine Forum on advancing equitable access to next-generation vaccines

EVI

• 2 Jun: New study makes economic case for placental malaria vaccine, with first-time mothers standing to benefit most

• 9 Jun: Powering Europe's pandemic response: EVI and partners to offer vaccine R&D expertise and resources to applicant developers through ISIDORe II

MDGH

• 30 Jan: MDGH starts its Phase 2 clinical trial of dovramilast in people with leprosy type 2 reaction

PDP Funder News/Announcements

• 11 Aug: The evidence behind medicines made in Africa. Unitaid

• 11 Aug: Tackling schistosomiasis in Tanzania's young children. Wellcome

• 18 Aug: Unitaid invests US$36 million to support evidence-based scale-up of innovative malaria prevention tools. Unitaid

• 24 Aug: Coefficient Giving’s Largest Grant Ever: $276 Million, Co-Funded With GiveWell, to the Against Malaria Foundation. Coefficient Giving

• 27 Aug: Four new projects to accelerate the next generation of antimalarial drugs amid rising drug resistance. EDCTP3

Funder Announcement Archives

     •     2014 PDP Funder Announcements

     •     2013 PDP Funder Announcements

New PDP Publications

•  29 Jun: Advancing global health innovation through Europe-Africa collaboration. Numerous PDPs

Other Reports/ Publications

• Jun: From innovation to impact: Building on 20 years of progress. Unitaid

• 13 Mar: From Commitments to Action: Practical Pathways for Health Financing in Africa. Global Health Strategies

Related Press Releases/ Announcements/Articles

• 2 Aug: With a Series of Big Donations, State Department Restores Some Global Health Aid. The New York Times

• 3 Aug: Scientists Warn Drug-Resistant Malaria Mutation Is Spreading Across Lake Victoria Basin. Health Policy Watch

• 3 Aug: The Accra Reset: Reimagining Global Health Governance in an Era of Fragmentation. Global Policy

• 3 Aug: Inside the trial for a vaccine to end malaria. The Telegraph

• 3 Aug: A new chapter for African medical innovation. Nature

• 3 Aug: Moderna’s Bundibugyo ebolavirus vaccine candidate enters first human trial, backed by CEPI. CEPI

• 4 Aug: Reforming global health for an age of mistrust, fragmentation and overlapping crises. Nature

• 4 Aug: Treatment trials for Ebola strain behind Congo outbreak show promise, WHO says. Reuters

• 4 Aug: Moderna begins first human trial of Bundibugyo Ebola vaccine. Reuters

• 4 Aug: Clinical, molecular, and in vitro evidence of artemisinin partial resistance in Ethiopian Plasmodium falciparum: a prospective, multisite, surveillance study. The Lancet

• 4 Aug: Scientists Warn Drug-Resistant Malaria Mutation Is Spreading Across Lake Victoria Basin. Health Policy Watch

• 4 Aug: Climate change is shifting malaria activity in Africa. CIDRAP

• 4 Aug: Revvity reveals plans to expand latent tuberculosis testing business at ADLM. 360Dx

• 4 Aug: As a weekly anti-HIV pill nears the market, vaccine research faces new hurdles. Science

• 4 Aug: Antimalaria pesticide may have backfired, helping mosquitoes find love. Science

• 4 Aug: An Invasive Mosquito Is Spreading With Alarming Speed, Threatening Africa’s Cities. The New York Times

• 5 Aug: Accelerating policy approval and uptake of the dual prevention pill in Zambia through early stakeholder engagement. AIDS Care

• 6 Aug: The Machine in Geneva’s Basement. Health Policy Watch

• 6 Aug: To stop Ebola, treat malaria. Devex

• 6 Aug: Ebola virus behind massive outbreak in DRC could be mutating, officials say. The Guardian

• 6 Aug: EXCLUSIVE: Here is the ‘Final Text’ of UN Political Declaration on Pandemics – Although its Adoption is Far From Guaranteed. Health Policy Watch

• 7 Aug: Alarming Ebola Spread Raises Question of Viral Mutation. Health Policy Watch

• 7 Aug: Gavi welcomes recommendation to include existing Ebola vaccine Ervebo in clinical trials for Bundibugyo virus disease. Gavi

• 7 Aug: Lawmakers seek to boost new antibiotic development. CIDRAP

• 7 Aug: Third meeting of the WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) for Bundibugyo virus disease outbreak response: meeting report, 31 July 2026. WHO

• 7 Aug: Ebola cases top 4,000 in DRC as WHO urges Ervebo vaccine trial. Al Jazeera

• 7 Aug: Nanophotonics offers new hope for early malaria diagnosis. Nature

• 10 Aug: Fridge-free vaccine passes first human trial, raising hopes for the hardest-to-reach. Gavi

• 10 Aug: How climate change is reshaping Africa's malaria risk. DW

• 10 Aug: Beyond restoration: Tipping points, leverage points and the reimagination of global health architecture. Global Public Health

• 10 Aug: White House Attempt to Control Science Grants is Blocked – For Now. Health Policy Watch

• 10 Aug: We prepared for Ebola — but not this Ebola. STAT

• 10 Aug: AI Philanthropy Should Buy the Breakthroughs Markets Won’t. CGD

• 11 Aug: India’s homegrown malaria vaccine still a couple of years away from potential rollout, says ICMR chief. The Print

• 11 Aug: Ebola deaths top 2,000 as scientists race to develop vaccine. UN News

• 11 Aug: Phase 3 trial of Ebola vaccine to begin within weeks in Congo. Healio

• 11 Aug: Why bioequivalence is central to Africa’s manufacturing future. USP

• 11 Aug: The race to develop a vaccine for world’s fastest spreading Ebola. Geneva Solutions

• 12 Aug: Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says. STAT

• 12 Aug: At the heart of accelerating chikungunya vaccine development for Africa. CEPI

• 13 Aug: A boost for chemical vaccination against malaria. Science

• 13 Aug: Chemovaccination with a late-liver-stage antimalarial induces durable immunity against malaria. Science

• 13 Aug: New vaccination approach turns mosquito bites into immunity boosters. News Medical

• 13 Aug: Aligning EU health innovation with public interest: insights from the new CEPS Report. Global Health Advocates

• 13 Aug: The precarious state of community engagement in African clinical trials: A systematic review of funding, workforce gaps, and the path to institutionalization. PLOS

• 13 Aug: Leading Malaria Scientist Warns Tools Alone Will Not End the Disease. Health Policy Watch

• 14 Aug: AI-created bacteriophage overcame resistant bacterial strains, but experts emphasize need for safeguards. CIDRAP

• 14 Aug: Scaling up malaria vaccines in Africa. BMJ

• 14 Aug: CEPI Board appoints Ibrahim Abubakar as new Chief Executive Officer. CEPI

• 14 Aug: Guiding principles for pragmatic randomised trials of tuberculosis treatments. The Lancet

• 15 Aug: The next global health architecture cannot exclude women. The Lancet

• 17 Aug: New malaria compound could simplify treatment with single dose. Health Tech World

• 17 Aug: We cannot afford to lose the fight against drug-resistant malaria. GHTC

• 17 Aug: New genetic mutations linked to malaria drug resistance discovered. News Medical

• 17 Aug: Why Unitaid’s incoming chief says global health must keep innovating. Devex

• 17 Aug: Scots scientists hail antimalarial compound as 'exciting step forward'. The Scotsman

• 18 Aug: High-Profile Departures Shake Up WHO Leadership, Tedros ‘Confidant’ Returns. Health Policy Watch

• 18 Aug: The Ebola situation is grave; we must use every tool we have to save lives. Gavi

• 18 Aug: In parts of the world, antibiotic overuse isn’t the problem — underuse is. STAT

• 18 Aug: Priorities for an African research agenda on climate, environment and maternal, newborn and child health. Frontiers

• 19 Aug: Lessons from another negative tuberculosis vaccine trial. The Lancet

• 19 Aug: Meet the mosquitoes helping scientists tackle malaria. LSTMH

• 19 Aug: NIH Lifts Ban on Research in South Africa. Health Policy Watch

• 19 Aug: SA and Zambia’s HIV shot dilemma: Demand versus supply. Bhekisisa 

• 19 Aug: CEPI 3.0 cross-cutting themes explained: Biosecurity. CEPI

• 19 Aug: Safety and immunogenicity of the synthetic carbohydrate conjugate vaccine, SF2a-TT15, against Shigella flexneri 2a in infants in Kenya: a phase 2a, age-descending, dose-escalating, double-blind, randomised, placebo-controlled study. The Lancet

• 19 Aug: Epidemiological impact of a dual-action insecticidal coating applied to Aedes aegypti breeding sites on dengue transmission in Colombia: a cluster-randomised trial. The Lancet

• 19 Aug: Insecticidal paints for vector and vector-borne disease control. The Lancet

• 19 Aug: Political Declaration on Pandemics is Modified Ahead of UN Meeting. Health Policy Watch

• 20 Aug: New studies to test whether existing Ebola vaccines can generate immune responses to Bundibugyo ebolavirus. CEPI

• 20 Aug: Gavi commits additional funding for Ebola response. Gavi

• 20 Aug: WHO delivers Ebola vaccine to DR Congo to see if it can protect against Bundibugyo strain. CIDRAP

• 20 Aug: Five years on from first vaccine, fight against malaria sees progress in Africa. RFI

• 20 Aug: Brazil Advances New Vaccine Approach for Plasmodium vivax Malaria. Medscape

• 21 Aug: From estimates to evidence: measuring the true burden of AMR. The Lancet

• 22 Aug: Expert Committee recommends local clinical trial waivers for generic lenacapavir. TWN

• 24 Aug: Tuberculosis testing enters a new era of access to innovation. Forbes

• 24 Aug: Four key ways our warming planet is affecting our health. Gavi

• 24 Aug: Resistant malaria parasites become increasingly prevalent across Ethiopia. News Medical

• 24 Aug: As Malaria Spreads, Africa Needs Data on Gene-Edited Mosquitos. Think Global Health

• 24 Aug: WHO updates guidelines for visceral leishmaniasis. The Lancet

• 25 Aug: Ebola (Bundibugyo) Day 100 – Tracking Progress on Medical Countermeasures. IPPS

• 25 Aug: University of Oxford and Serum Institute of India agree licence to advance the next-generation multi-stage malaria vaccine candidate component. Oxford University

• 25 Aug: Ebola at 100 Days: Lessons, Challenges and Achievements. Health Policy Watch

• 25 Aug: China is changing the shape of global health. The terms are still up for negotiation. Nature

• 25 Aug: 100 Day milestone of Ebola Bundibugyo outbreak must be a “wake up call” for pandemic preparedness, says pharma industry. IFPMA

• 25 Aug: Asia’s clinical research revolution: Why the world’s innovation centre is shifting east. Clinical Trials Arena

• 25 Aug: Safety and Preliminary Efficacy of Dengue Monoclonal Antibody in Adult Patients: A Randomized Clinical Trial. JAMA

• 25 Aug: Swiss non-profit drugmakers team up as funding shrinks. Swiss Info

• 26 Aug: African health ministers adopt new strategy to bolster medical regulatory systems. WHO

• 26 Aug: Mpox is back – and in new countries. How can this outbreak be contained?. The Guardian

• 26 Aug: CEPI faces huge Ebola vaccine funding shortfall. Devex

• 26 Aug: Novel TB vaccine candidate misses the mark in phase 3 trial in newborns. CIDRAP

• 26 Aug: African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials. CEPI

• 26 Aug: Mentorship initiatives supporting grant acquisition and research capacity among early-career African scientists: systematic review and meta-synthesis. The Lancet

• 27 Aug: Drug resistance could be behind twice as many Asian hospital deaths as we thought. Gavi

• 27 Aug: The next global health architecture must deliver more than reform. Health Policy Watch

• 27 Aug: New TB vaccines are moving closer. Is Africa ready?. Health Policy Watch

• 30 Aug: UK commits more than £100m from aid budget to cutting-edge health research. The Independent

• 30 Aug: South Africa Grapples With The Promise and Price of Injectable Lenacapavir to Prevent HIV. Health Policy Watch

• 31 Aug: Innovations in reagent manufacturing to support the global diagnostics supply chain. Frontiers

• 31 Aug: Clinical accuracy, performance, and usability of the Dragonfly point-of-care molecular diagnostic platform for mpox: a mixed-methods field evaluation in Uganda. The Lancet

Upcoming Meetings/  Webinars

--------------------------